An unexpected immunohistochemical profile in an ovarian lesion
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Of particular interest is the tumor’s expression of CD56, classically a
neuroendocrine marker, which in the ovary is usually associated with a granulosa
cell tumor or a small cell carcinoma. CD56 positivity in a Benner cell tumor has
never been reported.

ABSTRACT
A 27 year old female presented with pelvic pain and a palpable pelvic mass. Upon
histological examination, the cystic mass contained a multi-cellular lining with
nuclear grooves. Negative inhibin staining ruled out a follicular cyst and granulosa
cell tumor while pan-cytokeratin positivity suggested an epithelial lesion. The
lesion stained positive for thrombomodulin, ultimately suggesting a diagnosis of a
Brenner cell tumor, although CD56 positivity in the tumor questions the known
immunohistochemical profile of Brenner cell tumors. This unusual result opens the
door to future research into the role CD56 in the diagnosis of ovarian neoplasms.

INTRODUCTION

Figure 2. H&E stain of the tumor (40X). Straight arrows = nucleoli, curved = grooved nuclei.

A 27 year old woman presented with pelvic pain and a palpable pelvic mass.
Ultrasound revealed a 16 cm x 14 cm x 7 cm, thin-walled, cystic mass
emanating from the patient’s left ovary (Fig. 1). All other pelvic structures
appeared normal. Tumor markers (CA-125 and CEA), HCG, and a Pap Reflex
HPV screen were negative and her metabolic panel was normal. Surgical excision
was recommended in order to rule out the possibility of malignancy.
One month later, the patient underwent a
laporatomic ovarian cystectomy. The
surgical team visualized the cyst and then
performed pelvic washings. The surgeon
mobilized the left ovary out of the pelvis and
resected the cystic portion, leaving the
remaining ovarian parenchyma behind. The
specimen was sent to pathology in order to
determine a definitive diagnosis.

METHODS

CONSLUSIONS AND FUTURE WORK

Figure 1. Pelvic ultrasound revealing
a large cystic mass (lined in red).

The specimen was sectioned and stained with hematoxylin and eosin (H&E).
Based on the gross and microscopic appearance of the tumor, in addition to the
young age of the patient, the initial differential diagnosis included a follicular cyst
and a granulosa cell tumor. Both of these are known to express inhibin but not
cytokeratins (CK).1 Thus, these stains were performed. Because the initial
analysis did not definitely determine a diagnosis (see results), additional
immunohsitochemical (IHC) stains were performed:
1) CK7 and CK20 to confirm the ovarian origin of the tumor cells.1
2) Neuroendocrine markers (CD56, synaptophysin, chromogranin) to investigate
the possibility of a small cell carcinoma.2
3) Urothelial markers (uroplakin, thrombomodulin) to investigate the possibility of
a cystic Brenner cell tumor.3

RESULTS
Initial microscopic examination revealed a large, cystic lesion with a multi-layered
cellular lining. The cells had small nuclei, with occasional grooves and nucleoli.
There was some vacuolated cytoplasm (Fig. 2). The appearance of the tumor and
young age of the patient suggested a follicular cyst or granulosa cell tumor, both of
which stain for inhibin and not for pan-CK.1

However, the tumor did not stain for inhibin but did stain for pan-CK (Fig. 3A).
This result ruled out the possibility of a follicular cyst or granulosa cell tumor.
Additionally, the pan-cytokeratin positivity suggests a tumor of epithelial origin.1
Therefore, the differential diagnosis now had to
.
A
include cystic epithelial lesions in a young woman:
(1) cystadenoma, (2) small cell carcinoma, (3) cystic
Brenner cell tumor. These tumors are especially
important to distinguish because while Brenner cell
tumors and cystadenomas have a benign course,
most patient’s with small cell carcinoma die within 2
years of diagnosis.4
A cystadenoma was ruled out immediately due to the B
inconsistent histology of the patient’s tumor:
cystadenoma’s have a single layer of epithelium
(most often serous or mucinous).5
The results of the neuroendocrine staining revealed
a CD56 positive (Fig. 3B) but synaptophysin and
chromogranin negative tumor. This, in addition to the
patient’s normal serum calcium (which is often
elevated in patient’s with small cell carcinoma), was Figure 3. Pan-CK (A) and
sufficient to rule out the possibility of a small cell CD56 (B) positive sections of
the tumor (10X).
carcinoma.2
Additionally, CK7 positivity and lack of CK20 staining confirmed the ovarian origin
of the epithelial cells. The cells did not stain for uroplakin but stained focally
positive for thrombomodulin. Overall, the tumor’s immunohistochemical profile is
most consistent with a cystic Brenner cell tumor (Table 1).3
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Table 1. A comparison of the immunohistochemical profile of the patient’s tumor and a
Brenner cell tumor. CK = cytokeratin, TM = thrombomodulin, UP = uroplakin, (+) = focal
staining, ? = unknown.

Based on the immunohistochemical
profile and the morphologic features of
the tumor, the most likely diagnosis
remains a cystic Brenner cell tumor.
Brenner (or transitional) cell tumors of
the ovary compromise fewer than 5% of
ovarian epithelial neoplasms.5 The
tumors consist of
transitional
epithelium, with a uniform population of
small, stratified cells containing grooved
nuclei (Fig. 4).3,5 The tumors are almost
Figure 4. H&E stain of a known Brenner cell
always
benign
and
discovered tumor. Figure from Rubin’s Pathology.
incidentally.
However, the CD56 positivity of this tumor questions the known IHC profile of
Brenner cell tumors. Practically, Brenner cell carcinomas must be differentiated
from transitional cell carcinoma metastasis from the urinary bladder, from poorly
differentiated serous papillary carcinomas, which may show transitional-like areas,
and from small cell carcinoma of the ovary, which may morphologically resemble
Brenner cell carcinoma.6 To date, none of these mimics are known to consistently
express CD56.2,7,8 We hypothesize that Brenner cell tumors express CD56 and
that this marker will be clinically useful in distinguishing Brenner cell tumors from
lookalikes. We are currently working on staining multiple Brenner cell tumors, as
well as controls, for CD56 to investigate this hypothesis.

REFERENCES
1. Baker PM, Olivia E (2004). Immunohistochemistry as a tool in the differential diagnosis of
ovarian tumor: an update. Int J Gyn Path 24: 39-55.
2. McCluggage WG, Olivia E, Connolly LE, McBride HA, Young RH (2004). An
immunohistochemical analysis of ovarian small cell carcinoma of hypercalcemic type. Int
J Gynecol Pathol 23: 330-336.
3. Kondi-Pafiti A, Kairi-Vassilatou E, Iavazzo C, Vouza E, Mavrigiannaki P, Kleanthis C,
Vlahodimitropolous D, Liapis A (2012). Clinicopathological features and immunoprofile of
30 cases of Brenner ovarian tumors. Arch Gynecol Obstet 285: 1699-1702.
4. Estel R, Hackethal A, Kalder M, Munstedt K (2011). Small cell carcinoma of the ovary of
the hypercalcaemic type: an analysis of clinical and prognostic aspects of a rare disease
on the basis of cases published in the literature. Arch Gynecol Obstet 284: 1277-1282.
5. Rubin R, Strayer DS, Rubin E (2012). Rubin’s Pathology: Clinicopathologic Foundation of
Medicine (6th edition). Baltimore: Lippincott Williams & Wilkins.
6. Kurman RJ, Ellenson LH, Ronnett BM (2002). Blaustein's pathology of the female genital
tract (5th edition). New York: Springer.
7. Cho EY, Choi Y, Chae SW, Sohn JH, Ahn GH (2006). Immunohistochemical study of the
expression of adhesion molecules in ovarian serous neoplasms. Pathol Int 56: 62-70.
8. Hodges KB, Lopez-Beltra A, Emerson RE, Montironi R, Cheng L (2010). Clinical utility of
immunohistochemistry in the diagnoses of urinary bladder neoplasia. Appl
Immunohistochem Mol Morphol 18: 401-410.

